Medication info
Tanacet Tablets

Tanacet Tablets

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›37.5mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Daewon Biotech Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202000649 · Approved 2020.02.05 · Insurance code 057600550

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: Adjust the dose according to the severity of the patient's pain and response to treatment. Use the lowest effective dose for the shortest possible period. Do not use this product for longer than necessary. If long-term use is needed because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this product should be continued. Elderly patients Use the usual adult dose. However, when tramadol is administered orally to patients aged 75 years and older, the elimination half-life of tramadol increases by 17%; therefore, administer this product at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this product after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this product to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, allow at least 6 hours between doses and do not exceed 8 tablets per day.

Ingredients

Manufacturer
Daewon Biotech Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate pain
  • severe pain
  • acute pain
  • chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Adults: Adjust the dose according to the severity of the patient's pain and response to treatment. Use the lowest effective dose for the shortest possible period. Do not use this product for longer than necessary. If long-term use is needed because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this product should be continued. Elderly patients Use the usual adult dose. However, when tramadol is administered orally to patients aged 75 years and older, the elimination half-life of tramadol increases by 17%; therefore, administer this product at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this product after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this product to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, allow at least 6 hours between doses and do not exceed 8 tablets per day.

Precautions

This medication may burden the liver, so those who regularly consume more than three drinks a day should consult a physician or pharmacist before taking it. If any skin rash or allergic reaction occurs while using this medication, stop taking it immediately and consult a healthcare professional. Caution is necessary if there is a history of seizures or if taking medications that may trigger seizures due to the risk of seizures. Rarely, serious allergic reactions may occur, so immediate emergency care should be sought if symptoms like difficulty breathing or hives develop. Patients with acute bronchial asthma may find it difficult to breathe when taking this medication and should administer it under the supervision of a healthcare professional. Taking this medication with alcohol or central nervous system depressants may cause severe drowsiness, respiratory depression, or coma; therefore, co-administration should be avoided. Patients with head injuries or brain diseases need special attention due to the risk of respiratory depression and increased intracranial pressure when taking this medication. This medication has a risk of dependence or abuse, so it should be taken only in the exact dosage and duration as directed by a physician. Patients with impaired liver function must consult a physician before taking this medication, ensuring that they do not exceed the recommended dosage. Ultra-rapid metabolizers with specific genotypes may metabolize the active ingredient quickly, increasing the risk of respiratory depression, so alternative medications or dosage adjustments may be needed for these patients. Children under 12 years or adolescents under 18 years who have had certain surgeries should not take this medication, and those aged 12 to 18 should avoid it if there are special risk factors. Patients with sleep apnea or hypoxia should continuously monitor symptoms during treatment and consider dosage adjustment or discontinuation as necessary. This medication may cause hyponatremia, so elderly patients or those with risk factors should monitor for symptoms. Patients with hypersensitivity to this medication, those taking certain drugs, severe respiratory depression, or head injury should not take it. Pregnant or breastfeeding women must consult a physician before taking this medication, and breastfeeding mothers should avoid it if possible. Exercise caution when driving or operating machinery due to possible drowsiness or dizziness.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, hepatotoxicity, hyponatremia, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, indigestion, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, substance abuse, hallucinations, withdrawal syndrome, migraine, drowsiness, sensory loss, tremor, paresthesia, attention deficit, syncope, memory impairment, psychomotor hyperactivity, sedation, amnesia, perceptual disturbance, convulsion, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urinary disorders, erectile dysfunction, weakness, chest pain, emotional abnormalities, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, increased blood creatinine, anaphylactic reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, impact on emotional instability, delirium, suicidal ideation, muscle rigidity syndrome, movement disorders, serotonin syndrome, speech impairment, mydriasis, orthostatic hypotension, hepatitis, gait disturbance, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hypoprothrombinemia, fatigue, glutamic acid acidosis, high anion gap metabolic acidosis, fixed rash, weakness, fever, edema, rigidity, syncope, congestive heart failure, vertigo, stupor, exacerbation of migraine, involuntary muscle contractions, asthma, exertional dyspnea, cough, bronchitis, urinary retention, frequent urination, abnormal kidney function values, oliguria, increased sweating, urticaria, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of stomach cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased erythrocytes, decreased leukocytes, increased leukocytes, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, gastrointestinal bleeding, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal visual field, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, vertigo, dyspnea, stupor, migraine, speech disorder, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, indigestion, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory tract syndrome, ptyalism, agitation, nervousness, psychomotor hyperactivity, gastrointestinal symptoms, urticaria, rash, bronchospasm, toxic skin necrosis, allergic reaction, convulsions, serotonin syndrome, serotonin syndrome, respiratory depression, QT prolongation, drowsiness, coma, cardiac arrest, death, liver failure, tubular necrosis of the kidney, hypotension, extreme fatigue, loss of appetite, weight loss, withdrawal symptoms, panic attacks, severe anxiety, tinnitus, abnormal central nervous system reactions, opioid-induced hyperalgesia, adrenal insufficiency symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that is air-tight, at room temperature between 1 to 30 degrees Celsius. This storage helps maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.